Table 1. Baseline characteristics of coronary artery disease (CAD) patients and controls.
| Parameters | CAD patients (n=125) | Controls (n=105) | P value |
|---|---|---|---|
| Age (years) | 63.3±10.8 | 61.6±9.2 | 0.192 |
| Gender (Female/Male) | 101/24 | 83/22 | 0.741 |
| BMI (kg/m2) | 23.8±2.5 | 23.3±3.1 | 0.185 |
| Hypertension (n/%) | 103 (82.4) | 77 (73.3) | 0.097 |
| Diabetes (n/%) | 25 (20.0) | 17 (16.2) | 0.456 |
| Smoke (n/%) | 57 (45.6) | 49 (39.2) | 0.872 |
| Family history of CAD (n/%) | 34 (27.2) | 24 (22.9) | 0.450 |
| TG (mmol/L) | 1.76±0.93 | 1.65±0.82 | 0.347 |
| TC (mmol/L) | 4.85±1.62 | 4.52±1.50 | 0.773 |
| HDL-C (mmol/L) | 1.10±0.34 | 1.22±0.31 | 0.005 |
| LDL-C (mmol/L) | 2.88±1.12 | 2.60±0.98 | 0.047 |
| Gensini score | 47.50 (26.00–72.75) | 1.00 (1.00–2.00) | <0.001 |
| hs-CRP (mg/L) | 13.01 (18.09–29.38) | ||
| ESR (mm/H) | 26.52 (20.87–32.46) | ||
| TNF-α (pg/mL) | 44.93 (32.16–59.02) | ||
| IL-1β (pg/mL) | 4.29 (2.95–6.33) | ||
| IL-6 (pg/mL) | 36.74 (30.21–44.26) | ||
| IL-8 (pg/mL) | 46.84 (34.19-68.16) | ||
| IL-10 (pg/mL) | 22.50 (16.25–29.21) | ||
| IL-17 (pg/mL) | 63.09 (43.26–87.40) |
Data are reported as means±SD, median (25th–75th value), or count (percentage). P<0.05 was considered significant (t-test, Wilcoxon rank-sum test, or chi-squared test). BMI: body mass index; TG: triglyceride; TC: total cholesterol; HDL-C: fasting high-density lipoprotein cholesterol; LDL-C, fasting low-density lipoprotein cholesterol; hs-CRP: hypersensitive C-reactive protein; ESR: erythrocyte sedimentation rate; TNF-α: tumor necrosis factor α; IL: interleukin.